What does ADMA bio manufacturing — stock-based comp mean?

Reflects the non-cash expense recognized for equity-based awards granted to employees and executives within the manufacturing business unit. This metric is used to understand the cost of talent retention and alignment of incentives with shareholder interests.

ADMA Biologics ADMA ADMA Bio Manufacturing — Stock-Based Comp

Other segment segments

Plasma Collection Centers

$1.06M-17.4%

Similar metrics at other companies

VSATDefense And Advanced Technologies — Stock-Based Comp

$8.65M+30.6%

HXLComposite Materials — Stock-Based Comp

$3.4M+13.3%

SNDXBiopharmaceutical Cancer Therapeutics — Stock Based Compensation

$12.05M+16.1%

RRCShare Based Compensation Including Deferred Amounts

$15.33M+1.6%

APOAsset Management — Equity-based compensation

-$156M-57.6%

SYREStock-Based Comp

$12.81M+44.6%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's adma bio manufacturing — stock-based comp.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's ADMA bio manufacturing — stock-based comp?: ADMA Biologics (ADMA) reported ADMA bio manufacturing — stock-based comp of $0 in Q1 2026.
What does ADMA bio manufacturing — stock-based comp mean?: Reflects the non-cash expense recognized for equity-based awards granted to employees and executives within the manufacturing business unit. This metric is used to understand the cost of talent retention and alignment of incentives with shareholder interests.